TEKANAFIN
Back to Products10 mg /ml
| Form | Spray |
|---|---|
| Active Substance | Naftifine |
| Presentation | Vial 1% - 20 ml |
| Treatment Category | Dermatology |
CORPORATE
WMR&D
- WMR&D CENTER
- SCIENCE DEPARTMENT
-
PRODUCT DEVELOPMENT AND TECHNOLOGY TRANSFER
- WMINOLAB
BUSINESS STRATEGY
PRESS
-
WORLD MEDICINE IN PRESS
- PRESS RELEASES
- PRESS CENTER
- CORPORATE VIDEOS